Page 1 of Clinical Trials for ( SGX Pharmaceuticals AND Inc. ) [SPONSOR-COLLABORATORS], 5 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Last Updated: November 1, 2006
Condition(s): Leukemia, Myeloid, Acute
2
Terminated
Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Refractory Acute Myelogenous Leukemia (AML)
Last Updated: January 14, 2008
Condition(s): Acute Myelogenous Leukemia
3
Terminated
Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors
Last Updated: July 22, 2008
Condition(s): Advanced Cancer
4
Terminated
Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Solid Tumors
Last Updated: November 1, 2006
Condition(s): Neoplasms
5
Terminated
Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors
Last Updated: July 22, 2008
Condition(s): Advanced Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=SGX+Pharmaceuticals%2C+Inc.

Page 1 of Clinical Trials for ( SGX Pharmaceuticals AND Inc. ) [SPONSOR-COLLABORATORS], 5 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About